12 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Episodic Migraine #EBM ... Erenumab #Migraine #CGRP ... VisualAbstract #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Decompression Sickness - The physical examination revealed diffuse violaceous skin mottling over his trunk and arms
in the portal venous ... Clinical #Derm #EM ... Pneumatosis #CT #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... Fremanezumab #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Intravascular Complications of Central Venous Catheterization by Insertion Site
Complications in the Three-Choice Comparison, According to Insertion-Site
Complications of Central Venous ... #EBM #RCT #Central ... #Venous #Catheters ... Infections #Selection #NEJM
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis #EBM #Rheum #PsoriaticArthritis #Tofacitinib #Adalimumab #VisualAbstract #NEJM
or Adalimumab versus ... Psoriatic Arthritis #EBM ... VisualAbstract #NEJM
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction (VALIDATE-SWEDEHEART) #EBM #Cardiology #VALIDATE #SWEDEHEART #Bivalirudin #Heparin #PCI #VisualAbstract
Bivalirudin versus ... VALIDATE-SWEDEHEART) #EBM ... VisualAbstract #NEJM
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Alectinib versus ... Non–Small-Cell Lung Cancer #EBM ... VisualAbstract #NEJM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
Adjuvant Nivolumab versus ... Intention-to-Treat Population #EBM ... Ipilimumab #Melanoma #NEJM